CONMED Corporation Announces Quarterly Cash Dividend
August 12 2021 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today announced that its
Board of Directors has declared a quarterly cash dividend of $0.20
per share, payable on October 5, 2021 to all shareholders of record
as of September 15, 2021.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and other healthcare
professionals in a variety of specialties, including orthopedics,
general surgery, gynecology, thoracic surgery and gastroenterology.
For more information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risks posed to the Company’s business, financial
condition, and results of operations by the COVID-19 global
pandemic and the various government responses to the pandemic,
including deferral of surgeries, reductions in hospital and
ambulatory surgery center operating volumes, disruption to
potential supply chain reliability, as well as the risk factors
discussed in the Company's Annual Report on Form 10-K for the full
year ended December 31, 2020 and listed under the heading
Forward-Looking Statements in the Company’s most recently filed
Form 10-Q. Any and all forward-looking statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 and relate to the Company’s performance on a
going-forward basis. The Company believes that all forward-looking
statements made by it have a reasonable basis, but there can be no
assurance that management’s expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or
prove to be correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210812005568/en/
CONMED Corporation Todd Garner Chief Financial
Officer 727-214-2975 ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024